A randomised, double blind, placebo controlled trial with vitamin D <sub>3</sub> as an add on treatment to interferon β-1b in patients with multiple sclerosis — Merja Soilu‐Hänninen (2012) | RDL Network
A randomised, double blind, placebo controlled trial with vitamin D <sub>3</sub> as an add on treatment to interferon β-1b in patients with multiple sclerosis
Article 2012 en
Authors
MS
Merja Soilu‐Hänninen
JÅ
Julia Åivo
BL
Britt-Marie Lindström
Abstract
1 min read
EudraCT number 2007-001958-99 and ClinicalTrialsGov number NCT01339676.
Tom Solomon, Nguyen Minh Dung, Bridget Wills, Rachel Kneen, Mary Gainsborough, Tran Vinh Diet, Trần Thi Thúy, Hà Thị Loan, Vo Cong Khanh, David W. Vaughn, Sir Nicholas White, Jeremy Farrar
Jordi Bruix, Shukui Qin, Philippe Merle, Alessandro Granito, Yi‐Hsiang Huang, G. Bodoky, Marc Pracht, Osamu Yokosuka, Olivier Rosmorduc, В. В. Бредер, René Gérolami, Gianluca Masi, Paul J. Ross, Tianqiang Song, Jean-Pierre Bronowicki, Isabelle Ollivier‐Hourmand, Masatoshi Kudo, Ann‐Lii Cheng, Josep M. Llovet, Richard S. Finn, Marie-Aude LeBerre, ,
Jean Yves Blay, César Serrano, Michael C. Heinrich, John Zalcberg, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, Robin L. Jones, Steven Attia, Gina Z. D’Amato, Ping Chi, Peter Reichardt, Julie Meade, Kelvin Shi, Rodrigo Ruiz‐Soto, Suzanne George, Margaret von Mehren
Discussion(0)
No comments yet. Be the first to comment.